DUBLIN--(BUSINESS WIRE)--The "Whole Genome and Exome Sequencing Markets by Research, Clinical, Direct to Consumer, and AgriBio including Test Price and Volume Forecasts with Executive and Consultant Guides 2018 to 2022" report has been added to Research and Markets' offering.
Will all newborns receive Whole Genome Sequencing at birth? How fast will Direct to Consumer Testing grow? What sequencing technology will take the lead? What's holding the industry back? Where are the over 800 locations that have high throughput devices?
A plummeting of costs for Whole Genome Sequencing is creating a gold rush for market players. New consumers, new technologies, new specializations. In a situation reminiscent of the birth of the internet industry a wide range of well funded players are racing for market share on a truly global stage. The report forecasts the market size out to 2022. The report includes detailed breakouts for 14 countries and 5 regions.
Germline? Somatic? Direct to Consumer? Gene Expression? Find out about the technology in readily understood terms that explain the jargon. What are the issues? Find the opportunities, and the pitfalls. Understand growth expectations and the ultimate market forecasts for the next five years.
Market Trends
Factors Driving Growth
- Diagnostic Factors
- Interpreting the Code Otherwise.
- Changes in Agriculture.
- Fertility Technology Comes of Age
- Pathogen Challenges
Factors Limiting Growth
- Increased Competition Lowers Price
- Lower Costs.
- Healthcare Cost Concerns Curtail Growth.
- Wellness has a downside
- GMO Opposition Movement
Sequencing Instrumentation
- Instrumentation Tenacity.
- Declining Cost of Instruments Changes Industry Structure.
- LISTING of CURRENT INSTRUMENT SPECIFICATIONS.
- Long Reads - Further Segmentation.
- Linked Reads.
- New Sequencing Technologies
Key Topics Covered:
i. Whole Genome Sequencing Market - Strategic Situation Analysis
ii. Guide for Executives, Marketing, Sales and Business Development Staff
iii. Guide for Management Consultants and Investment Advisors
1. Introduction and Market Definition
2. Market Overview
3. Market Trends
4. WGES Recent Developments
5. Country Market Sizes - North America
6. Country Markets - Europe
7. Country Markets - Asia Pacific
8. Country Markets - Latin America, Africa & The Middle East
9. Global Market Summary
10. Vision of the Future of Whole Genome Sequencing
Appendices
I. United States Medicare System: January 2016 laboratory Fees Schedule - National Limit and Midpoint
II Methodology
II.1 Authors
II.2 Sources
Companies Mentioned
- 23andMe
- Agena Bioscience
- Amazon UK
- Ancestry.com
- AstraZeneca
- Athletigen
- Berry Genomics
- BGI Genomics Co. Ltd.
- Bio-Rad
- Complete Genomics - BGI
- Curoverse
- Danaher
- Dante Labs
- Fabric Genomics
- Floragenex
- GE Global Research
- Gene by Gene Ltd
- Genome.
- Helix
- Human Longevity, Inc.
- IBM Watson
- Konica Minolta
- Life Letters
- Lifecode
- Myriad Genetics
- NeoGenomics
- PerkinElmer
- Qiagen
- Roche Molecular Diagnostics
- Sequencing.com
- Siemens Healthcare
- Thermo Fisher
- Toolbox Genomics
- Veritas Genetics
- WGS
For more information about this report visit https://www.researchandmarkets.com/research/pqbns3/whole_genome_and